Unknown

Dataset Information

0

Treatment of hypertrophic scars and keloids using an intralesional 1470 nm bare-fibre diode laser: a novel efficient minimally-invasive technique.


ABSTRACT: Hypertrophic and keloid scars result from abnormal wound healing and can have a variable response to a number of available treatment modalities. The evolution of laser treatments in recent years has shown a wide range of clinical applications including their use in the treatment of scars. We investigated the effectiveness of a 1470 nm diode laser using an intralesional optical fibre delivery device in the treatment of hypertrophic and keloid scars. We evaluated its safety and efficacy as a novel and minimally invasive treatment alternative for scar modulation and volume reduction. A prospective cohort study was performed involving 21 patients with hypertrophic scars (HS) (n?=?9) and keloids (n?=?12) resulting from various aetiology. Patients were treated with one to three treatment sessions. Comprehensive evaluations were performed using the Vancouver Scar Scale, Doppler ultrasound, Cutometer, Mexameter and PeriCam PSI. Scar thickness was reduced by an average of 0.308?±?0.138 cm (p?

SUBMITTER: Li K 

PROVIDER: S-EPMC7728807 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Treatment of hypertrophic scars and keloids using an intralesional 1470 nm bare-fibre diode laser: a novel efficient minimally-invasive technique.

Li Ke K   Nicoli Fabio F   Cui Chunxiao C   Xi Wen Jing WJ   Al-Mousawi Ahmed A   Zhang Zheng Z   Balzani Alberto A   Neill Lindsay L   Sorge Roberto R   Tong Yun Y   Zhang Yixin Y  

Scientific reports 20201210 1


Hypertrophic and keloid scars result from abnormal wound healing and can have a variable response to a number of available treatment modalities. The evolution of laser treatments in recent years has shown a wide range of clinical applications including their use in the treatment of scars. We investigated the effectiveness of a 1470 nm diode laser using an intralesional optical fibre delivery device in the treatment of hypertrophic and keloid scars. We evaluated its safety and efficacy as a novel  ...[more]

Similar Datasets

| S-EPMC4173836 | biostudies-literature
| S-EPMC2922716 | biostudies-other
| S-EPMC4186912 | biostudies-literature
| S-EPMC9511989 | biostudies-literature
| S-EPMC4906112 | biostudies-literature
| S-EPMC10723692 | biostudies-literature
2022-07-04 | GSE207183 | GEO
| S-EPMC5551836 | biostudies-other
| S-EPMC10894764 | biostudies-literature
| S-EPMC7019927 | biostudies-literature